ロード中...
Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke
AIM: To examine the safety and efficacy of mesenchymal stem cell (MSC) therapy for intracerebral haemorrhage with neurological dysfunctions for a year. METHODS: MSC were ex vivo expanded from 29 mL (17-42 mL) autologous bone marrow. Patients were randomized to have two intravenous injections of auto...
保存先:
| 出版年: | World J Stem Cells |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5583532/ https://ncbi.nlm.nih.gov/pubmed/28928910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4252/wjsc.v9.i8.133 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|